NDT

Management of monoclonal gammopathy of renal significance: treatment standard ABSTRACT. Monoclonal gammopathy of renal significance (MGRS) is a heterogeneous group of clonal B cell or plasma cell proliferative disorders that cause ki

Management of monoclonal gammopathy of renal significance: treatment standard

doi.org/10.1093/ndt/...

Issues | Nephrology Dialysis Transplantation | Oxford Academic An official journal of the European Renal Association - European Dialysis and Transplant Association. Publishes peer-reviewed original clinical and laboratory research across the full range of nephrol...

😍 Check out the new March issue of NDT!

academic.oup.com/ndt/issue

Effects of Microplastics and Nanoplastics on the Kidneys Abstract. Plastics are hydrophobic carbon polymers with a half-life of approximately 500 years. The widespread production and environmental accumulation of

Effects of microplastics and nanoplastics on the kidneys

doi.org/10.1093/ndt/...

The updated global burden of chronic kidney disease: one death every 20 seconds Abstract. In 2024, Global Burden of Disease (GBD) updated the forecast of global cause-specific age-standardized death rates. Chronic kidney disease (CKD)

The updated global burden of chronic kidney disease: one death every 20 seconds

doi.org/10.1093/ndt/...

What do clinical trials teach us about the pathophysiology of human IgA nephropathy?

🆓 doi.org/10.1093/ndt/...

Oil supplementation and cardiovascular mortality in the dialysis population

doi.org/10.1093/ndt/...

Risk-based referral model to nephrologist specialist care in Stockholm

doi.org/10.1093/ndt/...

The multiple autoantibodies in anti-GBM disease

doi.org/10.1093/ndt/...

😍Did you already discover the NDT kidney art gallery?

era-online.org/ndt-kidney-a...

🤩Check it out and send us one of your own kidney images!

Volume 41 Issue 1 | Nephrology Dialysis Transplantation | Oxford Academic An official journal of the European Renal Association - European Dialysis and Transplant Association. Publishes peer-reviewed original clinical and laboratory research across the full range of nephrol...

🤩 Check out the new January issue of NDT!

academic.oup.com/ndt/issue/41/1

Anti-glomerular basement membrane disease—treatment standard ABSTRACT. We review the current standards of treatment and discuss novel developments in the pathophysiology, diagnosis, outcome prediction and management

Anti-glomerular basement membrane disease—treatment standard

doi.org/10.1093/ndt/...

Membranous nephropathy treatment standard ABSTRACT. Membranous nephropathy (MN) is characterized by deposition of immune complexes leading to thickening of glomerular basement membranes. Over time,

Membranous nephropathy treatment standard

doi.org/10.1093/ndt/...

How to individualize renoprotective therapy in obese patients with chronic kidney disease: a commentary by the Diabesity Working Group of the ERA ABSTRACT. The interrelated pandemics of obesity and type 2 diabetes mellitus (T2DM) are fuelling an increase in the prevalence of chronic kidney disease (C

How to individualize renoprotective therapy in obese patients with chronic kidney disease:

a commentary by the Diabesity Working Group of the ERA

doi.org/10.1093/ndt/...

When impact trials are not feasible: alternatives to study the impact of prediction models on clinical practice ABSTRACT. Patients with kidney disease have an uncertain future, with prognosis varying greatly per patient. To get a better idea of what the future holds

When impact trials are not feasible:

alternatives to study the impact of prediction models on clinical practice

doi.org/10.1093/ndt/...

How should we best manage the consequences of nephron loss in IgAN? Jackson Kim, Fahmeedah Kamal, Brittany Yeung, Richard Lafayette; How should we best manage the consequences of nephron loss in IgAN?, Nephrology Dialysis T

How should we best manage the consequences of nephron loss in IgAN?

doi.org/10.1093/ndt/...

Disease Modification in Immunoglobulin A Nephropathy Jonathan Barratt; Disease Modification in Immunoglobulin A Nephropathy, Nephrology Dialysis Transplantation, , gfaf259, https://doi.org/10.1093/ndt/gfaf259

Disease modification in IgA nephropathy

doi.org/10.1093/ndt/...

BK Polyomavirus-associated nephropathy – diagnostic and treatment standard ABSTRACT. BK polyomavirus (BKPyV) is recognized as a significant viral complication of kidney transplantation. Prompt immunosuppression reduction reduces e

BK Polyomavirus-associated nephropathy – diagnostic and treatment standard

🆓 doi.org/10.1093/ndt/...

Global, regional, and national burden of renal anemia, 1990 to 2019 and prediction to 2050

doi.org/10.1093/ndt/...

Cardiovascular involvement in ANCA-associated vasculitis ABSTRACT. Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a systemic necrotizing vasculitis with significant cardiovascular invo

Cardiovascular involvement in ANCA-associated vasculitis

doi.org/10.1093/ndt/...

Prevalence of reduced eGFR in European adults using KDIGO and age-adapted eGFR thresholds

doi.org/10.1093/ndt/...

The nonsteroidal mineralocorticoid receptor blocker esaxerenone reduces glomerular hyperfiltration and albuminuria

doi.org/10.1093/ndt/...

Effectiveness and safety of finerenone in IgA nephropathy patients

doi.org/10.1093/ndt/...

Management of monoclonal gammopathy of renal significance: treatment standard Abstract. Monoclonal gammopathy of renal significance (MGRS) is a heterogeneous group of clonal B-cell or plasma cell proliferative disorders that cause ki

Management of monoclonal gammopathy of renal significance: treatment standard

doi.org/10.1093/ndt/...

Kidney disease after hematopoietic stem cell transplant—treatment standard ABSTRACT. Hematopoietic stem cell transplant (HSCT) is a well-established procedure for malignant and nonmalignant conditions. Despite its therapeutic bene

Kidney disease after hematopoietic stem cell transplant —treatment standard

doi.org/10.1093/ndt/...

🤩Check out the new December issue of NDT!

academic.oup.com/ndt/issue/40...

Now online in @ndt-era.bsky.social – this article by Prof Daniel Gale shows how RaDaR data are accelerating drug development for rare kidney diseases – informing NICE appraisals, regulatory endpoints & clinical trials for IgA nephropathy, FSGS, C3G & Alport syndrome.

📄: ow.ly/L9HK50XqqqT

Nephrotoxicity of Conventional Chemotherapeutics: Part I — Platinum Compounds and Antimetabolite Agents Abstract. Anticancer therapies have significantly improved survival rates in patients with cancer; however, despite prophylactic measures, many conventiona

Nephrotoxicity of Conventional Chemotherapeutics: Part I — Platinum Compounds and Antimetabolite Agents

doi.org/10.1093/ndt/...

Trends in Nephrology: From reducing proteinuria with steroids to curing glomerulonephritis Glomerulonephritis (GN) is a subgroup of kidney disorders characterized by inflammation and injury at the glomerular filtration barrier manifesting as hype

Trends in nephrology: from reducing proteinuria with steroids to curing glomerulonephritis

doi.org/10.1093/ndt/...

Body roundness index and mortality risk in patients with chronic kidney disease: moving beyond the obesity paradox AbstractBackground. Body roundness index (BRI), an emerging anthropometric measure, has been shown to outperform body mass index (BMI) in predicting mortal

Body roundness index and mortality risk in patients with chronic kidney disease: moving beyond the obesity paradox

doi.org/10.1093/ndt/...

Cardio-renoprotective effects of SGLT2 inhibitors—the role of anaemia correction Sodium/glucose co-transporter 2 inhibitors (SGLT2i) slow the progression of chronic kidney disease (CKD) and heart failure without the risk of concomitant

Cardio-renoprotective effects of SGLT2 inhibitors—the role of anaemia correction

doi.org/10.1093/ndt/...